SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-17-000074
Filing Date
2017-04-20
Accepted
2017-04-20 16:15:00
Documents
3
Period of Report
2017-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 12960
2 AMENDMENT NO. 1 TO THE CREDIT AGREEMENT BY AND AMONG WELLS FARGO BANK, NATIONAL exh10-1.htm EX-10.1 45575
3 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-17-000074.txt   68893
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 17773181
SIC: 2834 Pharmaceutical Preparations